Results 51 to 60 of about 3,369,625 (303)

Childhood Hodgkin Lymphoma in Iran; survival and outcome

Pediatric Hematology Oncology Journal, 2020
Background: Staging has an important role in both defining the prognosis of Hodgkin lymphoma (HL) and choosing the best treatment protocol. This study was designed to evaluate the features of HL and estimate the survival rate in patients referred to ...
Azim Mehrvar, Maryam Tashvighi, Mahyar Nourian, Narjes Mehrvar, Raheb Ghorbani, Yasaman Sadeghi, Mardavig Alebouyeh, Mohammad Faranoush   +7 more
doaj   +1 more source

Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Studies have shown promising survival with the use of Extended Temozolomide (E-TMZ) as compared to Conventional six cycles of Temozolomide (C-TMZ) in malignant gliomas; however, the reports are mostly limited to retrospective studies ...
Menal Bhandari, Ajeet Kumar Gandhi, Bharti Devnani, Pavnesh Kumar, Daya Nand Sharma, Pramod Kumar Julka   +5 more
doaj   +1 more source

A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer. [PDF]

, 2019
The objective of this research was to develop a robust gene expression-based prognostic signature and scoring system for predicting overall survival (OS) of patients with high-grade serous ovarian cancer (HGSOC).
Hang, Bo, Jin, Yu-Lan, Mao, Jian-Hua, Snijders, Antoine M, Wang, Pin, Xiong, Guang-Wu, Yang, Shao-Min, Zhang, Xiao-Wei, Zhao, Yue   +8 more
core  

Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue [PDF]

, 2014
Five-year survival for patients with oral cancer has been disappointingly stable during the last decades, creating a demand for new biomarkers and treatment targets.
A Jemal, A Muller, A Pellegrino, A Zhu, A Zipin-Roitman, AF Ziober, AM Mulligan, BJ Moeller, BK Lo, C Beskow, C Grandi, CC Tong, CJ Hutchings, CL Addison, CT Allen, D Sano, E Montagna, Göran Laurell, HA Wolff, IK Kalnins, J Romanini, J Vandercappellen, J Wang, JN Sarkaria, K Annertz, K Kawada, K Kawada, KA Dinshaw, Karin Nylander, KB Pytynia, L Boldrup, L Goldberg-Bittman, L Lundqvist, Lotta Loljung, M Cojoc, M Fujita, M Liu, M Rentoft, M Rentoft, Matilda Rentoft, MF Calmon, MN Wente, N Sahu, P Silva, Philip John Coates, S Atula, S Friesland, S Matsumura, S Shintani, S Struyf, SP Schantz, SP Schantz, TC Walser, Torben Wilms, W Garavello, WA Yeudall, XL Lu, Y Matsuo   +57 more
core   +4 more sources

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma

Cancer Management and Research, 2019
Kexin Ma,* Bing Dong,* Liming Wang, Chongyu Zhao, Zhaoyu Fu, Chi Che, Wuguang Liu, Zexuan Yang, Rui LiangDepartment of Hepatobiliary Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China*These ...
Ma K, Dong B, Wang L, Zhao C, Fu Z, Che C, Liu W, Yang Z, Liang R   +8 more
doaj  

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer

Clinical and Translational Medicine, 2020
Accurate identification of patients with poor prognosis after radical surgery is essential for clinical management of colon cancer. Thus, we aimed to develop death and relapse specific radiomics signatures to individually estimate overall survival (OS ...
Weixing Dai, Shaobo Mo, Lingyu Han, Wenqiang Xiang, Menglei Li, Renjie Wang, Tong Tong, Guoxiang Cai   +7 more
doaj   +1 more source

Complete remission in metastatic hepatocellular carcinoma

JGH Open, 2023
Bone metastases from hepatocellular carcinoma (HCC) are unusual. Optimal treatment strategies are not well defined. The prognosis of this entity is very poor with a survival that does not exceed 1 year.
Wala Ben Kridis, Rim Kallel, Tahia Boudawara, Afef Khanfir   +3 more
doaj   +1 more source

Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy [PDF]

, 2019
The therapeutic management of recurrent malignant gliomas (MGs) is not determined. Therefore, the efficacy of a multimodal approach and a combination systemic therapy was investigated.
Bianco, Vincenzo, ELENA REBUZZI, Sara, Ferrara, Carla, Fusto, Carmela, GIRON BERRIOS, JULIO RODRIGO, Grassi, Massimiliano, Pecorari, Silvia, Prelaj, Arsela, Salvati, Maurizio, Stati, Valeria, Tomao, Silverio   +10 more
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait, R. Al‐Saadi, A. Lopez‐Cortes, K. Dzhuma, M. Oostveen, J. Brok, S. Irtan, M. Weeks, J. Bate, S. Baker, R. Williams, M. Powis, D. Saunders, O. Olsen, T. Watson, S. Shelmerdine, S. Vaidya, L. Howell, C. Duncan, G. M. Vujanic, C. Stiller, G. P. Balchin, T. Chowdhury, K. Pritchard‐Jones   +23 more
wiley   +1 more source

The extremity localized classic osteosarcomas have better survival than the axial non-classics

World Journal of Surgical Oncology, 2018
Background Osteosarcoma is one of the most malignant primary bone cancers, while is rarely reported in China. Of note, very few data of prognosis has been documented in this region.
Li Lin, Shaoyong Deng, Futing Zhang, Yaoze Liang, Zhenhua Huang   +4 more
doaj   +1 more source